Amneal Pharmaceuticals is a leading, privately owned, American developer, manufacturer, marketer and distributor of the highest quality generic drugs. Approximately 95% of Amneal products are made within one of five U.S. plants. Vertical integration and powerful global sourcing alliances allow better control of the product supply chain, ultimately providing Amneal customers with superior service levels and incredible value. All of these advantages enable Amneal to deliver on the promise to keep quality at the forefront of all processes and collaborative partnerships at the centre of the company’s focus.
Since the launch of the Amneal label in 2007, Amneal has enjoyed a meteoric rise in the United States, earning significant market share to become the 7th largest generics manufacturer in prescriptions dispensed 1, with the aim to become a top 5 generic company in the U.S. market through aggressive internal product growth, strategic acquisitions, value added partnerships and maximising customer value. Amneal and its alliance companies employ more than 3,300 people worldwide. Of those, nearly 20% are scientists based in one of five U.S. R&D centres or in one of two India research facilities.
The Philosophy that has driven Amneal’s remarkable success
Amneal is more than just a company. It’s a remarkable organisation with the utmost of standards and highest of ethics, driven by a strong sense of family values, the courage to develop breakthrough processes, a passionate commitment to customer value and superior operational execution.
1. September 2015 IMS Health data.